Daniel L Weinstein, 551445 Grandview Ave, Westfield, NJ 07090

2001002, Sep 27, 2001

Jan 5, 2001

09/755325

Daniel Weinstein - New York NY, US

The Rockefeller University

C07H021/04
C12P021/02
C12N005/06

536/023500, 435/325000, 435/069100, 530/381000

The present invention provides a vertebrate translation initiation factor (eIF-4AIII), that plays a role in the differentiation of an embryonic cell to an epidermal cell. This translation initiation factor interacts with BMP-4 in a positive regulatory loop. The nucleic acid and amino acid sequences are also disclosed. Also disclosed are methods of using the translation initiation factor, nucleic acids encoding the same, and corresponding antibodies and the like.

2003018, Sep 25, 2003

May 5, 2003

10/429997

Daniel Weinstein - New York NY, US

Rockefeller University, The - New York NY

C12N009/22
C07H021/04
C12P021/02
C12N005/06
C12N001/21
C12N015/74

536/023200, 435/069100, 435/320100, 435/325000, 435/252300, 435/199000

The present invention provides a vertebrate translation initiation factor (eIF-4AIII), that plays a role in the differentiation of an embryonic cell to an epidermal cell. This translation initiation factor interacts with BMP-4 in a positive regulatory loop. The nucleic acid and amino acid sequences are also disclosed. Also disclosed are methods of using the translation initiation factor, nucleic acids encoding the same, and corresponding antibodies and the like.

6197947, Mar 6, 2001

May 25, 1999

9/318443

Daniel C. Weinstein - New York NY

The Rockefeller University - New York NY

C07H 2104

536 235

The present invention provides a vertebrate translation initiation factor (eIF-4AIII), that plays a role in the differentiation of an embryonic cell to an epideimal cell. This translation initiation factor interacts with BMP-4 in a positive regulatory loop. The nucleic acid and amino acid sequences are also disclosed. Also disclosed are methods of using the translation initiation factor, nucleic acids encoding the same, and corresponding antibodies and the like.

6291651, Sep 18, 2001

Jan 12, 1999

9/228603

Daniel C. Weinstein - New York NY

The Rockerfeller University - New York NY

C07K 1600
C12N 512
C12P 2108

5303873

The present invention provides a unique src-family kinase (SFK) that plays a key role in the transformation of early-stage embryonic cells to mesodermal cells. Furthermore, this src-family kinase is likely to be a proto-oncogene. The nucleic acid and amino acid sequences are disclosed.

5952213, Sep 14, 1999

Jan 13, 1998

9/006675

Daniel C. Weinstein - New York NY

The Rockefeller University - New York NY

C12N 912
C12N 120
C12N 1500
C12N 500

435194

The present invention provides a unique src-family kinase (SFK) that plays a key role in the transformation of early-stage embryonic cells to mesodermal cells. Furthermore, this src-family kinase is likely to be a proto-oncogene. The nucleic acid and amino acid sequences are disclosed.

2022027, Sep 1, 2022

May 16, 2022

17/663492

- Crystal Lake IL, US
Charles D. Manice - Larchmont NY, US
Daniel W. Weinstein - New York NY, US

AptarGroup, Inc. - Crystal Lake IL

G16H 20/13
A61M 15/00
G09B 19/00
G16H 20/10
G16Z 99/00
G16H 40/63

An inhaler tracker module is secured to an inhaler and has an activation sensor for sensing use of the inhaler. The tracker module includes a memory for storing inhaler use data, and a communications component for wirelessly transmitting the stored inhaler use data. The tracker module is wrapped around the inhaler body and includes a pressure switch located at the top of the canister to detect a user pressing the canister into the body for inhaler use. The tracking module has a standby mode in which it remains until inhaler use or until inhaler use data is stored and it is transmitted. A pairing function is provided.

2018030, Oct 25, 2018

Apr 18, 2018

15/956586

- New York NY, US
Charles D. Manice - Larchmont NY, US
Daniel W. Weinstein - New York NY, US

Cohero Health, Inc. - New York NY

G16H 20/13
A61M 15/00

An inhaler use monitoring system includes a tracker module adaptable to be secured to a variety of inhalers and having an activation sensor for sensing user of the inhaler, an internal memory for storing inhaler data, and a communications component for forwarding the stored usage data to a processor for analyzing the data. The system then provides the user with incentives, e.g., redeemable award points, for usage of the inhaler in a desired manner. The tracking module can accommodate both controller and rescue inhalers. Optionally, the system may also collect lung function data, e.g., from a spirometer, and can then process all of controller inhaler data, rescue inhaler data and lung function data, to generate alerts and other messages e.g., redeemable award points.

2018027, Sep 27, 2018

May 31, 2018

15/994637

Daniel A. Weinstein - Newton MA, US
Reuben Weinstein - Newton MA, US

E02D 31/00
B32B 3/30
B32B 5/02
B32B 5/26
B32B 37/18
B32B 38/00

A containment material for a containment system to provide protection against the diffusion of contaminants in a containment area. A structured felt geotextile surface layer is joined with a geomembrane barrier layer to form a lamination. The geomembrane barrier layer is substantially impervious to liquid diffusion. The structured felt geotextile surface layer comprises a needle-punched, non-woven felt with an upper surface structured to have a surface pattern of peaks and valleys. A containment system is formed from a plurality of strips of containment material joined by liquid-impervious bonds to provide coverage to the containment area. A process for forming a containment material comprises providing a structured felt geotextile layer formed with first and second needling operations to produce a surface pattern and a liquid impervious geomembrane barrier layer and joining the layers to form a lamination.